L Catterton sells Thorne to Procter & Gamble
Analysis based on 7 articles · First reported Aug 04, 2026 · Last updated Aug 05, 2026
The acquisition of Thorne Research by Procter & Gamble for $3.8 billion in cash is expected to strengthen P&G's position in the fast-growing vitamins, minerals, and supplements market, potentially boosting its revenue growth. For L Catterton, the sale represents a successful exit, likely generating significant returns for its investors and reinforcing its reputation in consumer investments.
L Catterton, the largest global consumer-focused investment firm, announced on August 4, 2026, that it has signed a definitive agreement to sell Thorne Research, a leader in science-backed health and wellness solutions, to Procter & Gamble for $3.8 billion in cash. L Catterton had acquired Thorne Research in October 2023, identifying a shift in consumer behavior toward proactive, clinical-based products. During its ownership, L Catterton invested in Thorne Research's leadership, marketing, R&D, manufacturing, and technology, including the development of a proprietary AI wellness advisor. The transaction is expected to close in the fourth quarter of 2026. Financial advisors to Thorne Research were Perella Weinberg Partners and Canaccord Genuity, with Kirkland & Ellis as legal advisor; Jones Day acted as legal advisor to Procter & Gamble.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard